Trials / Enrolling By Invitation
Enrolling By InvitationNCT07166588
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.
Conditions
Timeline
- Start date
- 2021-01-20
- Primary completion
- 2026-12-31
- Completion
- 2028-12-31
- First posted
- 2025-09-10
- Last updated
- 2025-09-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07166588. Inclusion in this directory is not an endorsement.